[Erythroderma induced by teicoplanin].
We report the case of a 38-year old man who developed erythroderma during treatment with teicoplanin for staphylococcal septicaemia. The clinical symptoms, which included high fever, shock and erythroderma, were suggestive of staphylococcal toxic shock. After teicoplanin was withdrawn and replaced by vancomycin the disease followed a favourable course. The reintroduction test was positive. This case illustrates the problems associated with the diagnosis of erythroderma in intensive care patients and confirms that it is possible to prescribe vancomycin in cases with allergic reaction to teicoplanin.
Paul
C
C
Service de Dermatologie, Hôpital Saint-Joseph, Paris.
Janier
M
M
Carlet
J
J
Tamion
F
F
Carlotti
A
A
Fichelle
J M
JM
Daniel
F
F
D000328:Adult; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008297:Male; D018805:Sepsis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D017334:Teicoplanin / Q000009:adverse effects* / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
D017334:Teicoplanin; D014640:Vancomycin
Erythrodermie induite par la teicoplanine.